How Seminal Plasma Affects HIV-1 Infection
Author Information
Author(s): Julie A. Martellini, Amy L. Cole, Pavel Svoboda, Olga Stuchlik, Li-Mei Chen, Karl X. Chai, Bhushan K. Gangrade, Ole E. Sørensen, Jan Pohl, Alexander M. Cole
Primary Institution: University of Central Florida College of Medicine
Hypothesis
The study investigates how prostatic acid phosphatase peptides interact with human seminal plasma to influence HIV-1 infection.
Conclusion
Human seminal plasma can inhibit the HIV-1 enhancing activity of prostatic acid phosphatase peptides.
Supporting Evidence
- Prostatic acid phosphatase peptides can enhance HIV-1 infection in vitro.
- Human seminal plasma can neutralize the proviral activity of these peptides.
- The anti-HIV-1 activity of seminal plasma is concentration dependent.
- Proteolytic enzymes in seminal plasma degrade prostatic acid phosphatase peptides.
- Different methods of processing seminal plasma can affect its antiviral properties.
- Cell density and treatment duration influence the antiviral activity of seminal plasma.
- Variability in individual donor samples may affect the results.
Takeaway
This study found that a substance in semen can stop certain proteins from helping HIV infect cells.
Methodology
The study involved collecting human semen samples, processing them to obtain seminal plasma, and testing the effects of prostatic acid phosphatase peptides on HIV-1 infection in various assays.
Limitations
The study's findings may not fully represent in vivo conditions due to the controlled laboratory environment.
Participant Demographics
Human semen samples were collected from patients at the Center for Reproductive Medicine.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website